CALL/ILLUMINA/300/0.1/20.09.24 Stock

Warrant

DE000GP9XKS8

Real-time BOERSE MUENCHEN 08:26:47 2024-05-17 EDT
0.032 EUR -49.21% Intraday chart for CALL/ILLUMINA/300/0.1/20.09.24
Current month+85.29%
1 month+8.62%
Date Price Change
24-05-17 0.032 -49.21%
24-05-16 0.063 +85.29%
24-05-15 0.034 +6.25%
24-05-14 0.032 -11.11%
24-05-13 0.036 -12.20%

Real-time BOERSE MUENCHEN

Last update May 17, 2024 at 08:26 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ILLUMINA, INC.
Issuer Goldman Sachs
WKN GP9XKS
ISINDE000GP9XKS8
Date issued 2023-07-21
Strike 300 $
Maturity 2024-09-20 (126 Days)
Parity 10 : 1
Emission price 0.7
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.02
Lowest since issue 0.019
Delta0.06x
Omega 5.527
Premium163.1x
Gearing100.38x
Moneyness 0.3815
Difference Strike 187.7 $
Difference Strike %+62.55%
Spread 0.15
Spread %83.33%
Theoretical value 0.1020
Implied Volatility 87.96 %
Total Loss Probability 98.32 %
Intrinsic value 0.000000
Present value 0.1020
Break even 301.11 €
Theta-0.02x
Vega0.01x
Rho0x

Company Profile

Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and biotechnology companies. Net sales break down by source of income as follows: - product sales (84.1%): tools and instruments for sequencing, genotyping, genetic expression, etc.; - sales of services (15.9%). Net sales are distributed geographically as follows: the United States (52.4%), Americas (3.6%), Europe (25.3%), Asia/Pacific/Middle East/Africa (10.2%) and China/Taiwan/Hong Kong (8.5%).
Sector
-
More about the company

Ratings for Illumina, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Illumina, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
114.5 USD
Average target price
155.5 USD
Spread / Average Target
+35.86%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW